Obeticholic Acid: A Powerful FXR Agonist for Liver Health and Pharmaceutical Intermediates

Explore the therapeutic potential and applications of Obeticholic Acid, a key pharmaceutical intermediate and FXR agonist vital for liver disease treatment and drug development.

Get a Quote & Sample

Advantages Offered by the Product

Advanced FXR Agonism

Obeticholic Acid's potent FXR agonism makes it a highly effective compound for modulating liver functions and treating bile acid-related disorders, supporting comprehensive liver disease treatment.

Key Pharmaceutical Intermediate

As a vital pharmaceutical intermediate, it serves as a foundational element for creating advanced therapeutic agents, particularly in the realm of liver health and bile acid regulation.

Research and Development Catalyst

The drug development of Obeticholic Acid continues to expand, offering promising solutions for conditions like NASH and portal hypertension, driving innovation in medical treatments.

Key Applications

Liver Disease Treatment

Obeticholic Acid is extensively researched and utilized for treating primary biliary cholangitis, contributing to improved liver health outcomes and the management of chronic liver conditions.

Pharmaceutical Synthesis

Its role as a key pharmaceutical intermediate makes it indispensable in the synthesis of new drugs, supporting the pharmaceutical industry's drive for novel therapies.

Metabolic Regulation

Obeticholic Acid aids in regulating bile and cholesterol metabolism, which is critical for managing metabolic disorders linked to liver function and overall health.

Investigational Therapies

Ongoing studies explore Obeticholic Acid's potential in treating nonalcoholic steatohepatitis (NASH) and portal hypertension, showcasing its broad therapeutic scope.